This tender seeks suppliers for upstream cell culture hardware to support vaccine development and production in South Africa. The project aims to enhance local capabilities and requires timely delivery by February 2026.
The Medical Research Council of South Africa invites tenders for the supply and delivery of upstream cell culture hardware as part of the DSTI/KfW/SAMRC initiative aimed at bolstering vaccine development and production in South Africa. This project is critical for advancing local scientific research and enhancing the nation's capacity to produce vaccines, thereby contributing to public health and safety.
Suppliers are expected to provide high-quality equipment that meets specific technical requirements outlined in the tender documents. The successful bidder will play a vital role in ensuring that multiple beneficiaries, including research institutions and healthcare facilities, have access to state-of-the-art technology necessary for effective cell culture processes. Timely delivery by the closing date of February 27, 2026, is essential to align with project timelines and objectives, making this an excellent opportunity for businesses specializing in scientific equipment and technology.
This tender is suitable for businesses that manufacture or supply scientific research equipment, particularly those with experience in biotechnology and vaccine production. Companies capable of meeting technical specifications and timelines are encouraged to apply.
•••••• •••• ••••••• ••••• •••••• •••••• •••••• ••••.
Get full access to this tender, including documents, location, and contact details.